Computational guided drug repurposing for targeting 2′-O-ribose methyltransferase of SARS-CoV-2
Authors:
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 259, 118169
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Department of Biotechnology (BT/562/NE/U-Excel/2016, BT/PR24308/NER/95/644/2017)
This publication has 19 references indexed in Scilit:
- Stratégies de formation de la structure coiffe chez les virus à ARNmédecine/sciences, 2012
- Biochemical and Structural Insights into the Mechanisms of SARS Coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 Protein ComplexPLOS Pathogens, 2011
- Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2′-O-Methyltransferase nsp10/nsp16 ComplexPLOS Pathogens, 2011
- Coronavirus Genomics and Bioinformatics AnalysisViruses, 2010
- History of the Use of Ergotamine and Dihydroergotamine in Migraine From 1906 and OnwardCephalalgia, 2008
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- [20] VERIFY3D: Assessment of protein models with three-dimensional profiles1997
- Verification of protein structures: Patterns of nonbonded atomic interactionsProtein Science, 1993
- PROCHECK: a program to check the stereochemical quality of protein structuresJournal of Applied Crystallography, 1993
- Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replicationin vivoNucleic Acids Research, 1987